Related Experiment Video
Updated: May 27, 2025

12:46
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
2.4K
Distinct Cytokine Patterns Identify Acute and Convalescent Myocardial Involvement After Coronavirus Disease 2019: A
David A Zidar1,2,3, Grace A McComsey1,2, Donald D Anthony1,3
1Departments of Pathology and Medicine, Case Western Reserve University School of Medicine.
The Journal of Infectious Diseases
|February 19, 2025
Summary
Post-COVID-19 heart issues may stem from different inflammation than acute COVID-19 heart injury. Understanding these distinct mechanisms, involving interleukin-18 (IL-18), could guide targeted therapies for long COVID cardiac sequelae.
Area of Science:
- Immunology
- Cardiology
- Infectious Diseases
Background:
- Coronavirus disease 2019 (COVID-19) can lead to cardiac involvement, a significant post-acute sequela.
- The specific immunobiologic mechanisms driving cardiac issues in acute versus convalescent COVID-19 are not fully understood.
Purpose of the Study:
- To investigate the distinct immunobiologic underpinnings of cardiac involvement in acute and convalescent phases of COVID-19.
- To compare inflammatory profiles and cardiac status between acute and post-COVID-19 populations.
Main Methods:
- Integrated analysis of cytokine levels (Tumor Necrosis Factor alpha [TNF-α] and Interleukin-18 [IL-18]).
- Cardiac magnetic resonance imaging (CMR) to assess myocardial inflammation and edema.
- Cardiopulmonary exercise capacity testing.
Main Results:
- Acute cardiac injury was associated with elevated TNF-α but not IL-18.
- Convalescent myocardial inflammation/edema correlated with IL-18 levels, independent of TNF-α.
- Distinct inflammatory profiles were observed between acute and convalescent cardiac involvement.
Conclusions:
- Inflammation is not a uniform process in COVID-19-related cardiac involvement.
- Post-acute cardiac sequelae may arise from mechanisms differing from acute cardiac injury.
- Targeted therapies addressing specific inflammatory pathways (e.g., IL-18) may be crucial for preventing long COVID cardiac complications.

